Rosemary A. Crane
CIK: 0001443343
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jun 5, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct14.5K shares- - May 28, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Award(A)DirectRestricted Share Units
7.2K shares- - May 14, 2026CERT
Certara, Inc.
Exercise(M)Direct15.8K shares- - Jun 6, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct9.6K shares- - Jun 5, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Award(A)DirectRestricted Share Units
14.5K shares- - May 21, 2025CERT
Certara, Inc.
Exercise(M)Direct11.9K shares- - May 21, 2025CERT
Certara, Inc.
Award(A)DirectRestricted Stock Units
15.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 5, 2026 |  TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 14,492 | - | $0 | Direct |
| May 28, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Award(A) Restricted Share Units | 7,242 | - | - | Direct |
| May 14, 2026 |  CERT Certara, Inc. | Exercise(M) | 15,757 | - | $0 | Direct |
| Jun 6, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 9,632 | - | - | Direct |
| Jun 5, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Award(A) Restricted Share Units | 14,492 | - | - | Direct |
| May 21, 2025 | CERT Certara, Inc. | Exercise(M) | 11,928 | - | - | Direct |
| May 21, 2025 | CERT Certara, Inc. | Award(A) Restricted Stock Units | 15,757 | - | - | Direct |
1-7 of 7 transactions
About Crane Rosemary A
Crane Rosemary A (SEC CIK 0001443343) files insider reports with the SEC as Director of TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) and Director of Certara, Inc. (CERT).
Signal8 holds 5 ownership filings by Crane Rosemary A, all Form 4s, filed between May 22, 2025 and Jun 8, 2026. Those filings report 7 transactions, from May 21, 2025 to Jun 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Crane Rosemary A's filings is in TEL AVIV.
Recent filings by Crane Rosemary A
- Jun 5, 2026: Option exercise of TEVA shares (Form 4, code M).
- May 28, 2026: Grant or award of TEVA derivative securities (Form 4, code A).
- May 14, 2026: Option exercise of CERT shares (Form 4, code M).
- Jun 6, 2025: Option exercise of TEVA shares (Form 4, code M).
- Jun 5, 2025: Grant or award of TEVA derivative securities (Form 4, code A).
Other insiders filing for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
- Bergwerk Dov, Interim Cheif Legal Officer
- Savage Brian, Interim Chief Legal Officer
- MIGNONE ROBERTO, Director
- Weiss Amir, Chief Accounting Officer
- Satchi-Fainaro Ronit, Director
- Lippman Evan, EVP, Business Development